RFG Advisory’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.62M | Buy |
3,231
+850
| +36% | +$408K | 0.03% | 429 |
|
|
2026
Q1 | $1.17M | Buy |
2,381
+593
| +33% | +$322K | 0.02% | 505 |
|
|
2025
Q4 | $1.04M | Sell |
1,788
-334
| -16% | -$189K | 0.02% | 511 |
|
|
2025
Q3 | $1.03M | Sell |
2,122
-640
| -23% | -$298K | 0.02% | 481 |
|
|
2025
Q2 | $1.12M | Sell |
2,762
-1,973
| -42% | -$825K | 0.03% | 417 |
|
|
2025
Q1 | $2.36M | Buy |
4,735
+1,233
| +35% | +$668K | 0.06% | 241 |
|
|
2024
Q4 | $1.82M | Sell |
3,502
-151
| -4% | -$83K | 0.05% | 272 |
|
|
2024
Q3 | $2.26M | Buy |
3,653
+43
| +1% | +$25.5K | 0.07% | 221 |
|
|
2024
Q2 | $2M | Sell |
3,610
-87
| -2% | -$49.8K | 0.07% | 216 |
|
|
2024
Q1 | $2.15M | Buy |
3,697
+365
| +11% | +$205K | 0.07% | 206 |
|
|
2023
Q4 | $1.77M | Buy |
3,332
+494
| +17% | +$239K | 0.07% | 218 |
|
|
2023
Q3 | $1.44M | Buy |
2,838
+332
| +13% | +$177K | 0.06% | 218 |
|
|
2023
Q2 | $1.31M | Sell |
2,506
-130
| -5% | -$70.2K | 0.06% | 234 |
|
|
2023
Q1 | $1.52M | Sell |
2,636
-3
| -0.1% | -$1.69K | 0.07% | 198 |
|
|
2022
Q4 | $1.55M | Sell |
2,639
-348
| -12% | -$184K | 0.08% | 192 |
|
|
2022
Q3 | $1.47M | Buy |
2,987
+5
| +0.2% | +$2.8K | 0.08% | 184 |
|
|
2022
Q2 | $1.76M | Buy |
2,982
+55
| +2% | +$30.3K | 0.1% | 158 |
|
|
2022
Q1 | $1.73M | Sell |
2,927
-18
| -0.6% | -$10.3K | 0.11% | 125 |
|
|
2021
Q4 | $1.97M | Buy |
2,945
+214
| +8% | +$134K | 0.14% | 104 |
|
|
2021
Q3 | $1.56M | Buy |
2,731
+407
| +18% | +$223K | 0.13% | 118 |
|
|
2021
Q2 | $1.17M | Buy |
2,324
+205
| +10% | +$96.7K | 0.1% | 145 |
|
|
2021
Q1 | $967K | Buy |
2,119
+84
| +4% | +$40.1K | 0.11% | 153 |
|
|
2020
Q4 | $1.04M | Sell |
2,035
-183
| -8% | -$85.8K | 0.14% | 140 |
|
|
2020
Q3 | $979K | Buy |
2,218
+147
| +7% | +$60.7K | 0.14% | 139 |
|
|
2020
Q2 | $750K | Buy |
2,071
+163
| +9% | +$54.6K | 0.12% | 162 |
|
|
2020
Q1 | $541K | Buy |
1,908
+413
| +28% | +$130K | 0.1% | 175 |
|
|
2019
Q4 | $486K | Buy |
1,495
+678
| +83% | +$206K | 0.08% | 201 |
|
|
2019
Q3 | $238K | Buy |
817
+64
| +8% | +$18.3K | 0.05% | 282 |
|
|
2019
Q2 | $220K | Buy |
+753
| New | +$207K | 0.05% | 282 |
|
|
2018
Q4 | – | Sell |
-1,096
| Closed | -$268K | – | 307 |
|
|
2018
Q3 | $268K | Buy |
+1,096
| New | +$252K | 0.07% | 241 |
|
Other funds holding TMO
RFG Advisory's TMO Position: Q2 2026 in Review
RFG Advisory increased its Thermo Fisher Scientific (TMO) stake by 36% in Q2 2026, buying an estimated $408K and bringing the position to 3,231 shares worth $1.62M. The position accounts for 0.03% of the portfolio, ranked #429.
RFG Advisory first reported a position in TMO in Q3 2018 and has held it in 30 quarters since. The position peaked at $2.36M in Q1 2025. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- RFG Advisory held 3,231 shares of Thermo Fisher Scientific worth $1.62M as of Q2 2026.
- RFG Advisory bought 850 Thermo Fisher Scientific shares in Q2 2026, an estimated $408K.
- Thermo Fisher Scientific made up 0.03% of RFG Advisory's portfolio in Q2 2026, its #429 holding.
- RFG Advisory first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 30 quarters since.
- RFG Advisory's Thermo Fisher Scientific position peaked at $2.36M in Q1 2025.
- 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on RFG Advisory's 13F filing for Q2 2026, filed 15 Jul 2026.